Loreto Horcada

Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus

Íñigo Rúa‐Figueroa, María Galindo-Izquierdo, Jaime Calvo‐Alén et al. · Seminars in Arthritis and Rheumatism · 2017 · 157 citations · Full text

Life Sciences, Clinical Sciences, Immunology +12

Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER)

María Galindo-Izquierdo, Esther Rodríguez-Almaraz, José María Pego‐Reigosa et al. · Medicine · 2016 · 107 citations · Full text

Medicine, Immunology, Nephrology +13

Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER)

Anne Riveros-Frutos, Susana Holgado, Arantza Sanvisens Bergé et al. · Lara D. Veeken · 2020 · 64 citations

Life Sciences, Immunology, Autoimmunity +10

Comprehensive Description of Clinical Characteristics of a Large Systemic Lupus Erythematosus Cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) With Emphasis on Complete Versus Incomplete Lupus Differences

Íñigo Rúa‐Figueroa, Patricia Richi, Francisco Javier López-Longo et al. · Medicine · 2015 · 59 citations · Full text

Life Sciences, Clinical Sciences, Immunology +17

Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality

Leyre Riancho‐Zarrabeitia, Víctor Martínez‐Taboada, Íñigo Rúa‐Figueroa et al. · Lupus · 2020 · 52 citations · Full text

Life Sciences, Immunology, Autoimmunity +16